| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_536744f1fed8439775482b448beda1f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y201-03003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
| filingDate |
2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6978ba759c06a8843b91f404787c60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfda2177a6a9ba7d83f9d3dcbc9c3e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a22003d2bb2d5042c9cb1df142de35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6ee90fadf1acdf5bbf4fbe72421c0e2 |
| publicationDate |
2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210032438-A |
| titleOfInvention |
Methods and compositions of OTC constructs and vectors |
| abstract |
Provided herein are nucleic acids encoding ornithine transcarbamylase (OTC), such as nucleic acids comprising OTC codon-optimized sequences, as well as methods and compositions relating to related vectors such as AAV vectors. Also provided is a method of administering an AAV vector comprising a sequence encoding an enzyme associated with urea cycle disorder and an expression control sequence in combination with a synthetic nanocarrier coupled to an immunosuppressant. |
| priorityDate |
2018-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |